Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway (Vol 14, 99, 2015)MOLECULAR CANCERIF33.92024-10-180OAAI
The CoGAPS matrix factorization algorithm infers feedback mechanisms from therapeutic inhibition of EGFR that increases expression of growth factor receptorsCANCER RESEARCHIF16.62016-07-151PRE
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayMOLECULAR CANCERIF33.92015-05-0197OAAI
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell deathCANCER BIOLOGY & THERAPYIF4.62014-10-28105OAAI
Evidence for Radiation-Induced Disseminated Intravascular Coagulation as a Major Cause of Radiation-Induced Death in FerretsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52014-03-0121OAAI
Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor EffectsSCIENCE TRANSLATIONAL MEDICINEIF14.62013-02-06289OA
Potent anti-tumor effects of TIC10 require Foxo3a and TRAIL gene upregulationCANCER RESEARCHIF16.62012-04-010PRE
The small molecule TIC10 has potent anticancer efficacy mediated by induction of TRAIL production in normal and tumor cellsCANCER RESEARCHIF16.62011-04-010PRE